C
Channel Medsystems
Biotech & Life Sciences · San Francisco, United States · Founded 2009
Channel Medsystems - bringing innovation to the delivery of women’s healthcare MoreLess
Cerene is a medical technology company specializing in innovative treatments for heavy menstrual bleeding. The company's flagship product is a cryotherapy device designed to ablate the endometrial lining of the uterus in premenopausal women who have completed childbearing. This treatment is performed in the comfort of a doctor's office without the need for general anesthesia, making it a convenient and less invasive option for patients. Cerene primarily serves women suffering from heavy menstrual bleeding due to benign causes, aiming to improve their quality of life by offering a safe, effective, and cost-efficient solution. The company operates in the healthcare market, focusing on gynecological treatments. Cerene's business model involves selling its cryotherapy devices to healthcare providers, who then offer the treatment to patients. Revenue is generated through the sale of these devices and potentially through follow-up services and support. The company is committed to empowering women to take control of their health journeys by providing innovative and accessible medical technologies.
Keywords: cryotherapy, endometrial ablation, heavy menstrual bleeding, premenopausal women, gynecology, in-office treatment, medical device, patient comfort, healthcare, innovative technology.
Company overview
Channel Medsystems company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2009
- Headquarters
- San Francisco, United States
- Employees
- 30
- Open positions
- None listed
- Dealroom signal
- 57.2
Valuation & funding
Channel Medsystems funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | Aug 2026 | $30M | $120M | InnovaHealth Partners | ↗ |
| SERIES C✓Equity / VC | Aug 2017 | $14M | $56M | Longwood Fund · Third Point Ventures · Boston Scientific · InCube Ventures | — |
| SERIES C✓Equity / VC | Aug 2015 | $22M | $88M | Boston Scientific · Longwood Fund · InCube Ventures · Third Point Ventures | — |
| DEBT✓Debt | Oct 2014 | $6M | — | Undisclosed | — |
| SERIES C✓Equity / VC | Sep 2014 | — | — | Undisclosed | — |
| SERIES B✓Equity / VC | May 2013 | VentureHealth · Boston Scientific · InCube Ventures · Aperture Venture Partners | — | ||
| SERIES A✓Equity / VC | Feb 2012 | Undisclosed | — |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $1.2M | 0% | 30 |
| 2025 | $1.2M | 0% | 30 |
| 2024 | $1.2M | 0% | 30 |
| 2023 | $1.2M | 0% | 30 |
| 2022 | $1.2M | 0% | 30 |
| 2021 | $1.2M | 0% | 27 |
| 2020 | $1.2M | — | 17 |
Growth signals
Channel Medsystems website traffic
Latest recorded traffic for Channel Medsystems is 3.7K monthly website visits, up 146.7% over the last three months. Channel Medsystems's team grew 0% over the past year.
Comparisons
Channel Medsystems compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Channel Medsystems's talent
Source: Dealroom Talent Intelligence.
Investors
11 investors on Channel Medsystems's cap table
Sourced from Dealroom's funding and investor records.









Global footprint
Where Channel Medsystems has talent and traffic
In the news
Latest news about Channel Medsystems
Recent press, funding announcements, and product moves mentioning Channel Medsystems — open to read from the original sources.
Market sentiment
What the market is saying about Channel Medsystems
An AI-synthesized read of the highest-engagement posts about Channel Medsystems on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Channel Medsystems’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







